# 18F-FDG and 68Ga-FAPI PET/CT in Lung Adenocarcinoma

> **NCT04588064** · NA · COMPLETED · sponsor: **The First Affiliated Hospital of Xiamen University** · enrollment: 63 (actual)

## Conditions studied

- Lung Adenocarcinoma
- 18F-FDG
- 68Ga-FAPI
- PET/CT

## Interventions

- **DIAGNOSTIC_TEST:** 68Ga-FAPI PET/CT scan

## Key facts

- **NCT ID:** NCT04588064
- **Lead sponsor:** The First Affiliated Hospital of Xiamen University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-07-01
- **Primary completion:** 2022-07-01
- **Final completion:** 2022-07-01
- **Target enrollment:** 63 (ACTUAL)
- **Last updated:** 2025-01-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04588064

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04588064, "18F-FDG and 68Ga-FAPI PET/CT in Lung Adenocarcinoma". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT04588064. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*